Fisher Stewart

CIK 00018248631 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001824863

Recent Transactions

46 trades

Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16+2,250→ 131,371 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16$6.36/sh−661→ 130,710 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2024-09-16−2,250→ 14,250 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07+118,000→ 118,000 total
Disposition to Issuer
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07−94,950→ 0 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07+94,950→ 94,950 total
Disposition to Issuer
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-03-07−118,000→ 0 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-02-14+122,800→ 122,800 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-14+27,300→ 129,121 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-13$6.53/sh−2,255→ 101,821 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-09-18+120,000→ 120,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-08-30−2,250→ 16,500 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30+2,250→ 104,737 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30$2.93/sh−661→ 104,076 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-02-13+26,000→ 102,487 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-02-13+125,000→ 125,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-01-30−3,750→ 18,750 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30$7.78/sh−1,301→ 76,487 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30+3,750→ 77,788 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-26$7.01/sh−1,102→ 74,038 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-25+3,750→ 75,140 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-05-25−3,750→ 22,500 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-04-12$3.71/sh+2,156→ 45,462 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-04-12−2,156→ 35,572 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-04-12$4.98/sh+25,928→ 71,390 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-04-12−25,928→ 48,152 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-02-14+118,000→ 118,000 total
Award
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-02-14+26,250→ 26,250 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-12-08−403→ 203,994 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-12-08$4.98/sh+403→ 43,306 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-12-08−17,786→ 37,728 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-12-08$3.71/sh+17,786→ 42,903 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-12-08−2,373→ 0 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-12-08$2.11/sh+2,373→ 25,117 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-08-03$45.01/sh−17,057→ 22,744 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-08-02$45.00/sh−18,104→ 39,801 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-29$45.00/sh−50,211→ 57,905 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-02-11+94,950→ 94,950 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-02-03$3.71/sh+5,929→ 108,116 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-02-03−5,929→ 55,514 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-02-03$2.11/sh+2,371→ 102,187 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-02-03−2,371→ 2,371 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2020-12-11$3.71/sh+9,701→ 99,816 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2020-12-11−9,701→ 61,443 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2020-12-11−4,743→ 4,742 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2020-12-11$2.11/sh+4,743→ 90,115 total

Companies

C4 Therapeutics, Inc.
Chief Scientific Officer
$CCCC

Recent Filings

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472

View on SEC.gov